Uncover key drivers, emerging technologies, and competitive movements shaping the precision oncology market from 2025–2034 with trusted insights from The Business Research Company

What Is The Current Size And Growth Outlook For The Precision Oncology Market?

The precision oncology market has experienced significant growth in recent years. Projections indicate it will expand from $95.73 billion in 2024 to reach $106.21 billion by 2025, driven by a compound annual growth rate (CAGR) of 11.0%. This historical expansion can be attributed to several factors, including an increasing number of companion diagnostics approvals, a heightened focus on biomarker discovery and validation, growing investments in oncology research and innovation, a rise in precision oncology clinical trials, and an increasing preference for minimally invasive diagnostic techniques.

The precision oncology market is poised for significant expansion over the next few years, with its value forecast to reach $158.90 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.6%. This expected growth during the forecast period stems from factors such as the increasing prevalence of cancer, the rising adoption of genomics-based diagnostic tools, greater awareness among patients and clinicians, the expanding utilization of next-generation sequencing, and a growing demand for targeted cancer therapies. Prominent trends anticipated in the forecast period include advancements in liquid biopsy technologies, the sophisticated application of single-cell sequencing in tumor analysis, the development of decentralized testing platforms, innovations in radiogenomics for treatment planning, and progress in patient-specific cancer vaccines.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27395&type=smp

What Core Drivers Are Expected To Influence The Precision Oncology Market?

The future expansion of the precision oncology market is anticipated to be fueled by growing recognition and a move towards personalized therapeutic approaches. Personalized therapies are defined as treatments specifically tailored to an individual’s genetic composition, biological markers, and distinct disease attributes, aiming to boost efficacy and minimize adverse reactions. The proliferation of these therapies is attributed to breakthroughs in genomic technologies, which facilitate the accurate detection of disease-causing mutations, enabling more potent and targeted interventions. Precision oncology significantly contributes to the advancement of personalized therapies through the application of genomic and molecular profiling, which customizes cancer treatment to align with the unique genetic profile of a patient’s tumor. An illustrative example occurred in February 2023, when the Health and Social Care Secretary, per GOV.UK, a UK-based government department, entered into a Memorandum of Understanding with BioNTech SE to further cancer vaccine research in England, with an objective to provide 10,000 personalized therapy doses to UK patients by 2030. Consequently, the rising awareness and adoption of personalized therapies are indeed propelling the growth of the precision oncology market.

Which Segmentation Categories Are Highlighted In The Precision Oncology Market Analysis?

The precision oncology market covered in this report is segmented

1) By Type: Genomic Sequencing, Immunotherapy

2) By Product Type: Genetic Tests, Biomarker-Based Tests, Therapeutics

3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Skin Cancer, Stomach Cancer, Other Cancers

4) By Technology: Next-Generation Sequencing, Bioinformatics, Molecular Imaging, Liquid Biopsy

5) By End-users: Hospitals, Research Laboratories, Pharmaceutical Companies, Diagnostic Centers

Subsegments:

1) By Genomic Sequencing: Whole Genome Sequencing, Whole Exome Sequencing, Targeted Gene Sequencing

2) By Immunotherapy: Immune Checkpoint Inhibitors, Cancer Vaccines, Adoptive Cell Therapy

Which Market Trends Are Expected To Define The Future Of The Precision Oncology Market?

Leading firms within the precision oncology sector are concentrating on creating novel methodologies, like the molecular tumor board, to facilitate individualized treatment choices through the combination of genomic data and clinical understanding. A molecular tumor board is defined as a specialized group of experts who examine and decode intricate genomic and molecular test results to guide precise cancer treatments customized to each patient’s unique tumor traits. As an example, in December 2024, Aster DM Healthcare Ltd., a healthcare provider based in the UAE, launched a precision oncology clinic. This was one of three personalized cancer care programs aimed at revolutionizing treatment via data-driven, genomics-centered approaches. This clinic provides bespoke cancer therapy founded on the genetic profile of each patient’s tumor, leading to more accurate and potent treatments with fewer adverse effects. This methodology improves treatment results, lessens toxicity, and enhances quality of life by matching therapies to the distinct molecular attributes of a patient’s cancer.

Who Are The Dominant Players In The Precision Oncology Market Today?

Major companies operating in the precision oncology market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Bristol Myers Squibb Company, Thermo Fisher Scientific Inc., AstraZeneca plc., Novartis AG, Eli Lilly and Company, Amgen Inc., Agilent Technologies Inc., Illumina Inc., Sysmex Corporation, Qiagen N.V., Exact Sciences Corporation, NeoGenomics Laboratories Inc., Myriad Genetics Inc., Invitae Corporation, Caris Life Sciences, Foundation Medicine Inc., NanoString Technologies Inc., Personalis Inc., Strata Oncology Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/precision-oncology-global-market-report

Which Regional Markets Are Emerging As Key Hubs For The Precision Oncology Market?

North America was the largest region in the precision oncology market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the precision oncology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=27395&type=smp

Browse Through More Reports Similar to the Global Precision Oncology Market 2025, By The Business Research Company

Precast Concrete Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/precast-concrete-market

Drill Pipe Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/drill-pipe-global-market-report

Pipeline Construction Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/pipeline-construction-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model